These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8378855

  • 1. [The diagnostic significance of neutrophil adhesive reactions in rheumatoid arthritis].
    Fomina LL, Rakhmatullina AI.
    Ter Arkh; 1993; 65(6):72-6, 79. PubMed ID: 8378855
    [Abstract] [Full Text] [Related]

  • 2. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
    Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, Kuriyama M, Kipps TJ, Hashimoto H.
    J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
    [Abstract] [Full Text] [Related]

  • 3. Localized striated muscle vasculitis in rheumatoid arthritis.
    Ali Z, Ranganathan P, Perry A, Gelbart M.
    J Clin Rheumatol; 2007 Feb; 13(1):35-7. PubMed ID: 17278948
    [Abstract] [Full Text] [Related]

  • 4. Rheumatoid arthritis complicated by vasculitis.
    Hess EV.
    Hosp Pract (Off Ed); 1988 Oct 30; 23(10A):50-4, 57, 61-4 passim. PubMed ID: 2846599
    [No Abstract] [Full Text] [Related]

  • 5. Defective reticuloendothelial system C3b mediated clearance in rheumatoid arthritis and vasculitis.
    Cunningham TJ, Nicholls KM, Chen SL, Mathews JD, Muirden KD.
    J Rheumatol; 1985 Aug 30; 12(4):675-9. PubMed ID: 4057188
    [Abstract] [Full Text] [Related]

  • 6. [A basic study of determination matrix metalloproteinase-3 and carbohydrate in rheumatoid factor in serum for diagnosis of rheumatoid arthritis].
    Urata M, Nakamura N, Kinoshita S, Kayamori Y, Hamasaki N.
    Rinsho Byori; 2003 Aug 30; 51(8):745-50. PubMed ID: 13677934
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of polymorphonuclear leukocyte migration by sera of patients with rheumatoid arthritis.
    Attia WM, Clark HW, Brown TM, Ali MK, Bellanti JA.
    Ann Allergy; 1982 Jan 30; 48(1):21-4. PubMed ID: 7034594
    [Abstract] [Full Text] [Related]

  • 8. Gout masquerading as rheumatoid vasculitis.
    Sharma A, Baethge BA, Smith EB, Shepherd ME, Lisse JR.
    J Rheumatol; 1994 Feb 30; 21(2):368-9. PubMed ID: 8182655
    [Abstract] [Full Text] [Related]

  • 9. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
    Matsunawa M, Isozaki T, Odai T, Yajima N, Takeuchi HT, Negishi M, Ide H, Adachi M, Kasama T.
    Arthritis Rheum; 2006 Nov 30; 54(11):3408-16. PubMed ID: 17075825
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic and prognostic significance of so-called rheumatoid vasculitis].
    Häntzschel H, Otto W, Nasonova V, Alekberova Z, Reinelt D, Berger HD, Seidel W, Brehme M, Krause T, Lössner J.
    Z Gesamte Inn Med; 1984 Apr 01; 39(7):109-15. PubMed ID: 6730586
    [Abstract] [Full Text] [Related]

  • 11. Thalidomide effects in Behçet's syndrome and pustular vasculitis.
    Jorizzo JL, Schmalstieg FC, Solomon AR, Cavallo T, Taylor RS, Rudloff HB, Schmalstieg EJ, Daniels JC.
    Arch Intern Med; 1986 May 01; 146(5):878-81. PubMed ID: 3963978
    [Abstract] [Full Text] [Related]

  • 12. [Neutrophil migration in patients with rheumatoid arthritis (author's transl)].
    Seigneurin D, Montserrat C, Blanc D, Phelip X.
    Pathol Biol (Paris); 1981 Jan 01; 29(1):19-24. PubMed ID: 7010272
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec 01; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis of systemic vasculitis in rheumatoid arthritis patients (a clinico-immunomorphological study)].
    Saĭkovskiĭ RS, Nasonov EL, Timofeeva EB, Akhnazarova VD, Nasonova VA.
    Revmatologiia (Mosk); 1985 Dec 01; (2):36-9. PubMed ID: 3901191
    [No Abstract] [Full Text] [Related]

  • 15. [A case with rheumatoid arthritis complicated with ANCA-associated vasculitis].
    Amano K, Nakabayashi K, Tsuzaka K, Takeuchi T, Koide J, Abe T, Matsumura O.
    Ryumachi; 1998 Oct 01; 38(5):741-6. PubMed ID: 9852752
    [Abstract] [Full Text] [Related]

  • 16. Systemic rheumatoid vasculitis: a review.
    Genta MS, Genta RM, Gabay C.
    Semin Arthritis Rheum; 2006 Oct 01; 36(2):88-98. PubMed ID: 17023257
    [Abstract] [Full Text] [Related]

  • 17. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, Migliorini P.
    Rheumatology (Oxford); 2007 Oct 01; 46(10):1579-82. PubMed ID: 17717033
    [Abstract] [Full Text] [Related]

  • 18. [Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis].
    Revaz S, Dudler J.
    Rev Med Suisse; 2008 Mar 19; 4(149):712, 714, 716-7. PubMed ID: 18472732
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K.
    Ann Rheum Dis; 2004 Sep 19; 63(9):1079-84. PubMed ID: 15308516
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ.
    Arthritis Rheum; 2003 Oct 19; 48(10):2741-9. PubMed ID: 14558078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.